Similarly, the flavonoid phloretin increased the production of reactive oxygen species and dose-dependently decreased the expression of CDK2, CDK4, and cyclin D to ultimately inhibit the proliferation of human glioblastoma cells [20]. Here, CDK2 is linked to glioblastoma.